Stockreport
M&A Snapshot: Gilead acquires Arcellx for $7.8B [Seeking Alpha]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Subscribe to Newsletters Sign Up More on Gilead Sciences, Arcellx Time To Take Profits On Gilead Sciences (Rating Downgrade) Gilead Sciences, Inc. (GILD) Q4 2025 Earnings Call Transcript Gilead Sciences, Inc. 2025 Q4 - Results - Earnings Call Presentation Gilead in up to $1.5B deal with China's Genhouse Bio for tumor candidate Earnings Scorecard: Healthcare sector shows strong top-line pulse
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Gilead Sciences to Present at Upcoming Investor Conferences [Yahoo! Finance][Yahoo! Finance]
- Gilead Sciences to Present at Upcoming Investor Conferences[Business Wire]
- Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $170.00 price target on the stock.[MarketBeat]
- Gilead Sciences to Acquire Arcellx in $7.8 Billion Deal [Yahoo! Finance][Yahoo! Finance]
- Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion [Yahoo! Finance Canada][Yahoo! Finance Canada]
- More
GILD
SEC Filings
SEC Filings
- 2/23/26 - Form 8-K
- 2/18/26 - Form 4
- 2/18/26 - Form 4
- GILD's page on the SEC website
- More